Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine effects on brain activation in healthy women, women prone to depression, and women with fibromyalgia
NL-OMON28963Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of esketamine in major depressive disorder (MDD) and fibromyalgia (FM) (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Brain activity and connectivity and Plasma concentrations. Started Nov 2017; status: recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)fibromyalgia (FM)
Beyond the preview
Go deeper on NL-OMON28963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28963.